{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:35:16Z","timestamp":1790710516740,"version":"4.1.0"},"reference-count":249,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","award":["05\/00040174"],"award-info":[{"award-number":["05\/00040174"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503093"],"award-info":[{"award-number":["81503093"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672444"],"award-info":[{"award-number":["81672444"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972643"],"award-info":[{"award-number":["81972643"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.omto.2022.01.005","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T12:28:11Z","timestamp":1641817691000},"page":"400-416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"special_numbering":"C","title":["Carboranes as unique pharmacophores in antitumor medicinal chemistry"],"prefix":"10.1016","volume":"24","author":[{"given":"Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueshui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglian","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Hin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3249-1118","authenticated-orcid":false,"given":"Zhangang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2022.01.005_bib1","doi-asserted-by":"crossref","first-page":"12191","DOI":"10.1002\/anie.201407359","article-title":"\u03c0 aromaticity and three-dimensional aromaticity: two sides of the same coin?","volume":"53","author":"Poater","year":"2014","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.omto.2022.01.005_bib2","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1002\/anie.201100410","article-title":"A theta-shaped amphiphilic cobaltabisdicarbollide anion: transition from monolayer vesicles to micelles","volume":"50","author":"Bauduin","year":"2011","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.omto.2022.01.005_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1021\/ja203367h","article-title":"Mercaptocarborane-capped gold nanoparticles: electron pools and ion traps with switchable hydrophilicity","volume":"134","author":"Cioran","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.omto.2022.01.005_bib4","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1021\/jacs.6b02026","article-title":"Surface dipole control of liquid crystal alignment","volume":"138","author":"Schwartz","year":"2016","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.omto.2022.01.005_bib5","doi-asserted-by":"crossref","first-page":"16848","DOI":"10.1021\/ja105542j","article-title":"Bottom-up assembly of molecular wagons on a surface","volume":"132","author":"Villag\u00f3mez","year":"2010","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.omto.2022.01.005_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nchem.2686","article-title":"Atomically precise organomimetic cluster nanomolecules assembled via perfluoroaryl-thiol S(N)Ar chemistry","volume":"9","author":"Qian","year":"2017","journal-title":"Nat. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201704238","article-title":"Biomimetic inspired core-canopy quantum dots: ions trapped in voids induce kinetic fluorescence switching","volume":"29","author":"Saha","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omto.2022.01.005_bib8","doi-asserted-by":"crossref","first-page":"12131","DOI":"10.1021\/ja053050i","article-title":"Coordination-driven self-assemblies with a carborane backbone","volume":"127","author":"Jude","year":"2005","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.omto.2022.01.005_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1138690","article-title":"Imaging of single organic molecules in motion","volume":"316","author":"Koshino","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.omto.2022.01.005_bib10","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1021\/ja101845m","article-title":"Synthesis and properties of carborane-appended C(3)-symmetrical extended pi systems","volume":"132","author":"Dash","year":"2010","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.omto.2022.01.005_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0010-8545(02)00112-1","article-title":"Advances in the chemistry of metallacarboranes of f-block elements","volume":"231","author":"Xie","year":"2002","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.omto.2022.01.005_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/ar010146i","article-title":"Cyclopentadienyl-carboranyl hybrid compounds: a new class of versatile ligands for organometallic chemistry","volume":"36","author":"Xie","year":"2003","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.omto.2022.01.005_bib13","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.ccr.2013.02.004","article-title":"Transition metal complexes based on carboranyl ligands containing N, P, and S donors: synthesis, reactivity and applications","volume":"257","author":"Yao","year":"2013","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.omto.2022.01.005_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1021\/ar100156f","article-title":"Transition metal-carboryne complexes: synthesis, bonding, and reactivity","volume":"44","author":"Qiu","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.omto.2022.01.005_bib15","doi-asserted-by":"crossref","first-page":"9906","DOI":"10.1002\/anie.201705857","article-title":"Fusing dicarbollide ions with N-heterocyclic carbenes","volume":"56","author":"Estrada","year":"2017","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.omto.2022.01.005_bib16","doi-asserted-by":"crossref","first-page":"15758","DOI":"10.1021\/jacs.6b10232","article-title":"Blue phosphorescent zwitterionic iridium(III) complexes featuring weakly coordinating nido-carborane-based ligands","volume":"138","author":"Axtell","year":"2016","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.omto.2022.01.005_bib17","doi-asserted-by":"crossref","first-page":"12868","DOI":"10.1002\/anie.201606979","article-title":"A bis(silylene)-substituted ortho-carborane as a superior ligand in the nickel-catalyzed amination of arenes","volume":"55","author":"Zhou","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.omto.2022.01.005_bib18","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1021\/cr200038x","article-title":"Carbaboranes as pharmacophores: properties, synthesis, and application strategies","volume":"111","author":"Scholz","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.omto.2022.01.005_bib19","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1021\/cr2000866","article-title":"Boron in drug discovery: carboranes as unique pharmacophores in biologically active compounds","volume":"111","author":"Issa","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.omto.2022.01.005_bib20","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1039\/b709843j","article-title":"The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy","author":"Armstrong","year":"2007","journal-title":"Dalton Trans."},{"key":"10.1016\/j.omto.2022.01.005_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0010-8545(02)00087-5","article-title":"The medicinal chemistry of carboranes","volume":"232","author":"Valliant","year":"2002","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.omto.2022.01.005_bib22","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1039\/C9CS00169G","article-title":"Controlled functionalization of o-carborane via transition metal catalyzed B-H activation","volume":"48","author":"Quan","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.omto.2022.01.005_bib23","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/chem.201704937","article-title":"Transition-Metal-Catalyzed selective cage B-H functionalization of o-carboranes","volume":"24","author":"Quan","year":"2018","journal-title":"Chemistry"},{"key":"10.1016\/j.omto.2022.01.005_bib24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ccr.2017.11.006","article-title":"Transition metal-induced B-H functionalization of o-carborane","volume":"378","author":"Zhang","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.omto.2022.01.005_bib25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1039\/C8CC08693A","article-title":"Metal-catalyzed cross-coupling chemistry with polyhedral boranes","volume":"55","author":"Dziedzic","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.omto.2022.01.005_bib26","doi-asserted-by":"crossref","first-page":"7494","DOI":"10.1039\/C9DT01140D","article-title":"Nucleophilic substitution: a facile strategy for selective B-H functionalization of carboranes","volume":"48","author":"Quan","year":"2019","journal-title":"Dalton Trans."},{"key":"10.1016\/j.omto.2022.01.005_bib27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ccr.2017.07.006","article-title":"BH activation of carboranes induced by late transition metals","volume":"350","author":"Yu","year":"2017","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.omto.2022.01.005_bib28","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1021\/acscatal.0c05639","article-title":"Catalytic cage BH functionalization of carboranes via \u201ccage walking\u201d strategy","volume":"11","author":"Guo","year":"2021","journal-title":"ACS Catal."},{"key":"10.1016\/j.omto.2022.01.005_bib29","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3390\/molecules25040828","article-title":"Boron chemistry for medical applications","volume":"25","author":"Ali","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.omto.2022.01.005_bib30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/cac2.12089","article-title":"Boron neutron capture therapy: current status and future perspectives","volume":"40","author":"Dymova","year":"2020","journal-title":"Cancer Commun. (Lond)"},{"key":"10.1016\/j.omto.2022.01.005_bib31","first-page":"330","article-title":"Theranostics in boron neutron capture therapy","volume":"11","author":"Sauerwein","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.omto.2022.01.005_bib32","doi-asserted-by":"crossref","first-page":"e1250","DOI":"10.1002\/onco.13805","article-title":"Designation products: boron neutron capture therapy for head and neck carcinoma","volume":"26","author":"Kanno","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.omto.2022.01.005_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbrc.2021.04.037","article-title":"Tumor-targeting hyaluronic acid\/fluorescent carborane complex for boron neutron capture therapy","volume":"559","author":"Yamana","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omto.2022.01.005_bib34","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.3390\/ijms22052772","article-title":"Design, synthesis, and evaluation of novel 3-carboranyl-1,8-naphthalimide derivatives as potential anticancer agents","volume":"22","author":"Rykowski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omto.2022.01.005_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.apradiso.2013.01.001","article-title":"Boron neutron capture therapy and 18F-labelled borophenylalanine positron emission tomography: a critical and clinical overview of the literature","volume":"74","author":"Evangelista","year":"2013","journal-title":"Appl. Radiat. Isot"},{"key":"10.1016\/j.omto.2022.01.005_bib36","doi-asserted-by":"crossref","first-page":"601820","DOI":"10.3389\/fonc.2021.601820","article-title":"Boron neutron capture therapy: a review of clinical applications","volume":"11","author":"Malouff","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omto.2022.01.005_bib37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1039\/D0TB01880E","article-title":"Pre-targeting with ultra-small nanoparticles: boron carbon dots as drug candidates for boron neutron capture therapy","volume":"9","author":"Feiner","year":"2021","journal-title":"J.\u00a0Mater. Chem. B"},{"key":"10.1016\/j.omto.2022.01.005_bib38","doi-asserted-by":"crossref","first-page":"13955","DOI":"10.1039\/C9CC03924D","article-title":"Intracellular target delivery of cell-penetrating peptide-conjugated dodecaborate for boron neutron capture therapy (BNCT)","volume":"55","author":"Nakase","year":"2019","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.omto.2022.01.005_bib39","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1021\/mp400641u","article-title":"One stone kills three birds: novel boron-containing vesicles for potential BNCT, controlled drug release, and diagnostic imaging","volume":"11","author":"Chen","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omto.2022.01.005_bib40","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4155\/fmc.13.47","article-title":"Applications and perspectives of boron-enriched nanocomposites in cancer therapy","volume":"5","author":"Yinghuai","year":"2013","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib41","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1021\/acs.biomac.6b00929","article-title":"Dendrimers as innovative radiopharmaceuticals in cancer radionanotherapy","volume":"17","author":"Liko","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.omto.2022.01.005_bib42","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/cmdc.202000983","article-title":"Preparing (Metalla)carboranes for nanomedicine","volume":"16","author":"Gozzi","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.omto.2022.01.005_bib43","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.3390\/ijms22136762","article-title":"Metallacarborane derivatives effective against Pseudomonas aeruginosa and Yersinia enterocolitica","volume":"22","author":"Swietnicki","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omto.2022.01.005_bib44","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1038\/s41598-021-95044-0","article-title":"Boron rich nanotube drug carrier system is suited for boron neutron capture therapy","volume":"11","author":"Heide","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omto.2022.01.005_bib45","doi-asserted-by":"crossref","first-page":"107269","DOI":"10.1016\/j.polymertesting.2021.107269","article-title":"Original boron cluster covalent with poly-zwitterionic BODIPYs for boron neutron capture therapy agent","volume":"100","author":"Zhao","year":"2021","journal-title":"Polym. Test."},{"key":"10.1016\/j.omto.2022.01.005_bib46","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1002\/adma.201200420","article-title":"Biologically responsive polymeric nanoparticles for drug delivery","volume":"24","author":"Colson","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.omto.2022.01.005_bib47","first-page":"35","article-title":"Boron delivery agents for neutron capture therapy of cancer","volume":"38","author":"Barth","year":"2018","journal-title":"Cancer Commun. (Lond)"},{"key":"10.1016\/j.omto.2022.01.005_bib48","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/ph13120471","article-title":"Conjugates containing two and three trithiolato-bridged dinuclear ruthenium(II)-Arene units as in\u00a0vitro antiparasitic and anticancer agents","volume":"13","author":"Studer","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.omto.2022.01.005_bib49","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.3390\/molecules26133801","article-title":"Ruthenacarborane and quinoline: a promising combination for the treatment of brain tumors","volume":"26","author":"Dra\u010da","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.omto.2022.01.005_bib50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1039\/C4FD00098F","article-title":"Precious metal carborane polymer nanoparticles: characterisation of micellar formulations and anticancer activity","volume":"175","author":"Barry","year":"2014","journal-title":"Faraday Discuss."},{"key":"10.1016\/j.omto.2022.01.005_bib51","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1039\/C3DT53589D","article-title":"A multinuclear 1H, 13C and 11B solid-state MAS NMR study of 16- and 18-electron organometallic ruthenium and osmium carborane complexes","volume":"43","author":"Barry","year":"2014","journal-title":"Dalton Trans."},{"key":"10.1016\/j.omto.2022.01.005_bib52","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1166\/jnn.2006.449","article-title":"Polymeric nanostructures for drug delivery applications based on Pluronic copolymer systems","volume":"6","author":"Xiong","year":"2006","journal-title":"J.\u00a0Nanosci Nanotechnol."},{"key":"10.1016\/j.omto.2022.01.005_bib53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijpharm.2018.11.064","article-title":"Pluronics: intelligent building units for targeted cancer therapy and molecular imaging","volume":"556","author":"Khaliq","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.omto.2022.01.005_bib54","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.2147\/IJN.S171794","article-title":"Cyclic RGD-conjugated Pluronic(\u00ae) blending system for active, targeted drug delivery","volume":"13","author":"Lim","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.omto.2022.01.005_bib55","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2015.04.032","article-title":"Recent progress in biomedical applications of Pluronic (PF127): pharmaceutical perspectives","volume":"209","author":"Akash","year":"2015","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omto.2022.01.005_bib56","doi-asserted-by":"crossref","first-page":"2000200","DOI":"10.1002\/ppsc.202000200","article-title":"Therapeutic pretargeting with gold nanoparticles as drug candidates for boron neutron capture therapy","volume":"37","author":"Feiner","year":"2020","journal-title":"Part. Part. Syst. Charact."},{"key":"10.1016\/j.omto.2022.01.005_bib57","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1021\/acs.biomac.6b01845","article-title":"Carborane derivative conjugated with gold nanoclusters for targeted cancer cell imaging","volume":"18","author":"Wang","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.omto.2022.01.005_bib58","doi-asserted-by":"crossref","first-page":"55564","DOI":"10.1021\/acsami.0c15251","article-title":"Covalent organic polymer as a carborane carrier for imaging-facilitated boron neutron capture therapy","volume":"12","author":"Shi","year":"2020","journal-title":"ACS Appl. Mater. Inter."},{"key":"10.1016\/j.omto.2022.01.005_bib59","doi-asserted-by":"crossref","first-page":"5583","DOI":"10.1002\/chem.201905150","article-title":"Covalent organic frameworks (COFs) for cancer therapeutics","volume":"26","author":"Guan","year":"2020","journal-title":"Chemistry"},{"key":"10.1016\/j.omto.2022.01.005_bib60","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1039\/D1TB00041A","article-title":"Strategies and applications of covalent organic frameworks as promising nanoplatforms in cancer therapy","volume":"9","author":"Valenzuela","year":"2021","journal-title":"J.\u00a0Mater. Chem. B"},{"key":"10.1016\/j.omto.2022.01.005_bib61","doi-asserted-by":"crossref","first-page":"409320","DOI":"10.1155\/2010\/409320","article-title":"Boron drug delivery via encapsulated magnetic nanocomposites: a new approach for BNCT in cancer treatment","volume":"2010","author":"Zhu","year":"2010","journal-title":"J.\u00a0Nanomater."},{"key":"10.1016\/j.omto.2022.01.005_bib62","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/ijms20020449","article-title":"Bactericidal and cytotoxic properties of silver nanoparticles","volume":"20","author":"Liao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omto.2022.01.005_bib63","first-page":"78","article-title":"[Molecular mechanisms of anthracyclines action]","volume":"60","author":"Szu\u0142awska","year":"2006","journal-title":"Postepy Hig Med. Dosw (Online)"},{"key":"10.1016\/j.omto.2022.01.005_bib64","doi-asserted-by":"crossref","first-page":"11147","DOI":"10.1021\/acs.chemrev.5b00116","article-title":"Clinical translation of nanomedicine","volume":"115","author":"Min","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.omto.2022.01.005_bib65","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.2147\/IJN.S243223","article-title":"Nanoparticle drug delivery system for glioma and its efficacy improvement strategies: a comprehensive review","volume":"15","author":"Li","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.omto.2022.01.005_bib66","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12272-020-01219-0","article-title":"Advances in colon-targeted nano-drug delivery systems: challenges and solutions","volume":"43","author":"Naeem","year":"2020","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.omto.2022.01.005_bib67","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3109\/03639045.2016.1160103","article-title":"Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin","volume":"42","author":"Zhang","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.omto.2022.01.005_bib68","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1021\/acs.biomac.5b01311","article-title":"Doxorubicin-loaded carborane-conjugated polymeric nanoparticles as delivery system for combination cancer therapy","volume":"16","author":"Xiong","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.omto.2022.01.005_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001117","article-title":"Biomineralization: an opportunity and challenge of nanoparticle drug delivery systems for cancer therapy","volume":"9","author":"Wang","year":"2020","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.omto.2022.01.005_bib70","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.omto.2022.01.005_bib71","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.31306","article-title":"Evolution of systemic therapy for hepatocellular carcinoma","volume":"73","author":"Finn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.omto.2022.01.005_bib72","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omto.2022.01.005_bib73","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/nrdp.2016.18","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omto.2022.01.005_bib74","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/gutjnl-2020-321702","article-title":"Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups","volume":"70","author":"Pinter","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.omto.2022.01.005_bib75","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41575-020-00405-1","article-title":"Pursuing efficacious systemic therapy for hepatocellular carcinoma","volume":"18","author":"Cheng","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omto.2022.01.005_bib76","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2015.02.022","article-title":"Asialoglycoprotein receptor mediated hepatocyte targeting\u2014strategies and applications","volume":"203","author":"D'Souza","year":"2015","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omto.2022.01.005_bib77","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.biomaterials.2008.11.027","article-title":"Galactosylated fluorescent labeled micelles as a liver targeting drug carrier","volume":"30","author":"Wu","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.omto.2022.01.005_bib78","doi-asserted-by":"crossref","first-page":"110397","DOI":"10.1016\/j.colsurfb.2019.110397","article-title":"Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma","volume":"182","author":"Zhang","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.omto.2022.01.005_bib79","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1073\/pnas.1303437110","article-title":"Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes","volume":"110","author":"Kueffer","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.omto.2022.01.005_bib80","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tranon.2017.05.003","article-title":"Validation and comparison of the therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes in multiple murine tumor models","volume":"10","author":"Maitz","year":"2017","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.omto.2022.01.005_bib81","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2019.01.045","article-title":"Aptamer-functionalized liposomes for targeted cancer therapy","volume":"448","author":"Moosavian","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omto.2022.01.005_bib82","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/jcp.27121","article-title":"Liposomal nanocarriers for statins: a pharmacokinetic and pharmacodynamics appraisal","volume":"234","author":"Askarizadeh","year":"2019","journal-title":"J.\u00a0Cell Physiol."},{"key":"10.1016\/j.omto.2022.01.005_bib83","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/pharmaceutics12111054","article-title":"Liposome-based drug delivery systems in cancer immunotherapy","volume":"12","author":"Gu","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omto.2022.01.005_bib84","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1073\/pnas.95.5.2531","article-title":"Model studies directed toward the application of boron neutron capture therapy to rheumatoid arthritis: boron delivery by liposomes in rat collagen-induced arthritis","volume":"95","author":"Watson-Clark","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.omto.2022.01.005_bib85","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bbrc.2019.11.144","article-title":"PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT)","volume":"522","author":"Lee","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omto.2022.01.005_bib86","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3389\/fphar.2019.00808","article-title":"PEG-derivatized dual-functional nanomicelles for improved cancer therapy","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omto.2022.01.005_bib87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/diagnostics9030087","article-title":"Combined strategies with poly (ADP-Ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer: a literature review","volume":"9","author":"Boussios","year":"2019","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.omto.2022.01.005_bib88","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/acs.jmedchem.9b01136","article-title":"Selective neuropeptide Y conjugates with maximized carborane loading as promising boron delivery agents for boron neutron capture therapy","volume":"63","author":"Worm","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib89","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1039\/C9DT02130B","article-title":"Modular triazine-based carborane-containing carboxylic acids\u2014synthesis and characterisation of potential boron neutron capture therapy agents made of readily accessible building blocks","volume":"48","author":"Kellert","year":"2019","journal-title":"Dalton Trans."},{"key":"10.1016\/j.omto.2022.01.005_bib90","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1021\/acs.joc.9b02406","article-title":"A selective carborane-functionalized gastrin-releasing peptide receptor agonist as boron delivery agent for boron neutron capture therapy","volume":"85","author":"Hoppenz","year":"2020","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib91","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1039\/C9DT04031E","article-title":"Tuning a modular system\u2014synthesis and characterisation of a boron-rich s-triazine-based carboxylic acid and amine bearing a galactopyranosyl moiety","volume":"49","author":"Kellert","year":"2020","journal-title":"Dalton Trans."},{"key":"10.1016\/j.omto.2022.01.005_bib92","doi-asserted-by":"crossref","first-page":"e3119","DOI":"10.1002\/psc.3119","article-title":"A stable meta-carborane enables the generation of boron-rich peptide agonists targeting the ghrelin receptor","volume":"24","author":"Worm","year":"2018","journal-title":"J.\u00a0Pept. Sci."},{"key":"10.1016\/j.omto.2022.01.005_bib93","doi-asserted-by":"crossref","first-page":"14652","DOI":"10.1002\/slct.202004077","article-title":"Novel carborane compounds based on cyclooxygenase-2 inhibitors for effective boron neutron capture therapy of tongue squamous cell carcinoma","volume":"5","author":"Zhang","year":"2020","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.omto.2022.01.005_bib94","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","article-title":"Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas","volume":"107","author":"Eberhart","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omto.2022.01.005_bib95","first-page":"991","article-title":"Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck","volume":"59","author":"Chan","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2022.01.005_bib96","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/cncr.32010","article-title":"Cyclooxygenase-2 in gastrointestinal malignancies","volume":"125","author":"Nagaraju","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.omto.2022.01.005_bib97","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jcmm.12650","article-title":"MicroRNA expression and its implications for diagnosis and therapy of tongue squamous cell carcinoma","volume":"20","author":"Yu","year":"2016","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.omto.2022.01.005_bib98","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.oraloncology.2017.02.015","article-title":"MicroRNAs in human tongue squamous cell carcinoma: from pathogenesis to therapeutic implications","volume":"67","author":"Karatas","year":"2017","journal-title":"Oral Oncol."},{"key":"10.1016\/j.omto.2022.01.005_bib99","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13402-015-0259-z","article-title":"Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study","volume":"39","author":"Duz","year":"2016","journal-title":"Cell Oncol. (Dordr)"},{"key":"10.1016\/j.omto.2022.01.005_bib100","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3389\/fonc.2019.01370","article-title":"Role of matrix metalloproteinases in angiogenesis and cancer","volume":"9","author":"Quintero-Fabi\u00e1n","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omto.2022.01.005_bib101","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.critrevonc.2019.02.010","article-title":"Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer","volume":"137","author":"Gonzalez-Avila","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.omto.2022.01.005_bib102","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omto.2022.01.005_bib103","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.matbio.2018.01.002","article-title":"Extracellular matrix contribution to skin wound re-epithelialization","volume":"75-76","author":"Rousselle","year":"2019","journal-title":"Matrix Biol."},{"key":"10.1016\/j.omto.2022.01.005_bib104","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/cmdc.202000470","article-title":"Carborane-containing matrix metalloprotease (MMP) ligands as candidates for boron neutron-capture therapy (BNCT)","volume":"15","author":"Lutz","year":"2020","journal-title":"ChemMedChem."},{"key":"10.1016\/j.omto.2022.01.005_bib105","doi-asserted-by":"crossref","first-page":"19274","DOI":"10.1038\/s41598-020-76370-1","article-title":"In\u00a0vitro and in\u00a0vivo BNCT investigations using a carborane containing sulfonamide targeting CAIX epitopes on malignant pleural mesothelioma and breast cancer cells","volume":"10","author":"Alberti","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omto.2022.01.005_bib106","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.omto.2022.01.005_bib107","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/med.21497","article-title":"Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one","volume":"38","author":"Supuran","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.omto.2022.01.005_bib108","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/cancers12061616","article-title":"How and why are cancers acidic? Carbonic anhydrase IX and the homeostatic control of tumour extracellular pH","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omto.2022.01.005_bib109","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-018-0782-4","article-title":"Mechanisms of receptor tyrosine kinase activation in cancer","volume":"17","author":"Du","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omto.2022.01.005_bib110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-018-0796-y","article-title":"Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omto.2022.01.005_bib111","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12943-019-1090-3","article-title":"AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omto.2022.01.005_bib112","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ceb.2020.01.016","article-title":"Receptor tyrosine kinase activation: from the ligand perspective","volume":"63","author":"Trenker","year":"2020","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.omto.2022.01.005_bib113","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.3390\/cancers12113423","article-title":"Sunitinib-containing carborane pharmacophore with the ability to inhibit tyrosine kinases receptors FLT3, KIT and PDGFR-\u03b2, exhibits powerful in\u00a0vivo anti-glioblastoma activity","volume":"12","author":"Alam\u00f3n","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omto.2022.01.005_bib114","doi-asserted-by":"crossref","first-page":"14335","DOI":"10.1002\/chem.202002963","article-title":"Bimodal therapeutic agents against glioblastoma, one of the most lethal forms of cancer","volume":"26","author":"Couto","year":"2020","journal-title":"Chemistry"},{"key":"10.1016\/j.omto.2022.01.005_bib115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10895-020-02637-5","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of fluorescently labeled borocaptate-containing liposomes","volume":"31","author":"Kanygin","year":"2021","journal-title":"J.\u00a0Fluoresc"},{"key":"10.1016\/j.omto.2022.01.005_bib116","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1002\/chem.201701965","article-title":"Small-molecule kinase-inhibitors-loaded boron cluster as hybrid agents for glioma-cell-targeting therapy","volume":"23","author":"Couto","year":"2017","journal-title":"Chemistry"},{"key":"10.1016\/j.omto.2022.01.005_bib117","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3389\/fonc.2018.00653","article-title":"New prostate cancer targets for diagnosis, imaging, and therapy: focus on prostate-specific membrane antigen","volume":"8","author":"Cimadamore","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omto.2022.01.005_bib118","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/med.21508","article-title":"Targeting prostate cancer: prostate-specific membrane antigen based diagnosis and therapy","volume":"39","author":"W\u00fcstemann","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.omto.2022.01.005_bib119","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1021\/acs.molpharmaceut.9b00464","article-title":"Synthesis and initial biological evaluation of boron-containing prostate-specific membrane antigen ligands for treatment of prostate cancer using boron neutron capture therapy","volume":"16","author":"Wang","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omto.2022.01.005_bib120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41391-019-0174-x","article-title":"Lutetium-177 prostate-specific membrane antigen (PSMA) theranostics: practical nuances and intricacies","volume":"23","author":"Iravani","year":"2020","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.omto.2022.01.005_bib121","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3390\/cancers13092244","article-title":"More than meets the eye: scientific rationale behind molecular imaging and therapeutic targeting of prostate-specific membrane antigen (PSMA) in metastatic prostate cancer and beyond","volume":"13","author":"Hyv\u00e4kk\u00e4","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omto.2022.01.005_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2018.08.009","article-title":"Epidermal growth factor receptor: structure-function informing the design of anticancer therapeutics","volume":"371","author":"Mitchell","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.omto.2022.01.005_bib123","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omto.2022.01.005_bib124","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-030-30651-9_8","article-title":"Receptor tyrosine kinases: principles and functions in glioma invasion","volume":"1202","author":"Nakada","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omto.2022.01.005_bib125","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/cbin.11340","article-title":"Epidermal growth factor receptor (EGFR) involvement in epithelial-derived cancers and its current antibody-based immunotherapies","volume":"44","author":"London","year":"2020","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.omto.2022.01.005_bib126","doi-asserted-by":"crossref","first-page":"16535","DOI":"10.1002\/chem.201702957","article-title":"Versatile method for the site-specific modification of DNA with boron clusters: anti-epidermal growth factor receptor (EGFR) Antisense oligonucleotide case","volume":"23","author":"Ebenryter-Olbi\u0144ska","year":"2017","journal-title":"Chemistry"},{"key":"10.1016\/j.omto.2022.01.005_bib127","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3390\/molecules22091393","article-title":"High boron-loaded DNA-oligomers as potential boron neutron capture therapy and antisense oligonucleotide dual-action anticancer agents","volume":"22","author":"Kaniowski","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.omto.2022.01.005_bib128","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1039\/C9NR06550D","article-title":"Boron clusters as a platform for new materials: composites of nucleic acids and oligofunctionalized carboranes (C(2)B(10)H(12)) and their assembly into functional nanoparticles","volume":"12","author":"Kaniowski","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.omto.2022.01.005_bib129","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3390\/biom10050718","article-title":"Metallacarborane complex boosts the rate of DNA oligonucleotide hydrolysis in the reaction catalyzed by snake venom phosphodiesterase","volume":"10","author":"Kaniowski","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.omto.2022.01.005_bib130","doi-asserted-by":"crossref","first-page":"19193","DOI":"10.1021\/jacs.9b09106","article-title":"De novo carborane-containing macrocyclic peptides targeting human epidermal growth factor receptor","volume":"141","author":"Yin","year":"2019","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.omto.2022.01.005_bib131","doi-asserted-by":"crossref","first-page":"9241","DOI":"10.1002\/jcp.29819","article-title":"Versatile role of curcumin and its derivatives in lung cancer therapy","volume":"235","author":"Ashrafizadeh","year":"2020","journal-title":"J.\u00a0Cell Physiol."},{"key":"10.1016\/j.omto.2022.01.005_bib132","doi-asserted-by":"crossref","first-page":"103324","DOI":"10.1016\/j.bioorg.2019.103324","article-title":"Design, synthesis and preliminary in-vitro studies of novel boronated monocarbonyl analogues of Curcumin (BMAC) for antitumor and \u03b2-amyloid disaggregation activity","volume":"93","author":"Azzi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib133","doi-asserted-by":"crossref","first-page":"111631","DOI":"10.1016\/j.ejmech.2019.111631","article-title":"Curcumin analogues and their hybrid molecules as multifunctional drugs","volume":"182","author":"Noureddin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib134","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/antiox9121228","article-title":"Anti-viral potential and modulation of Nrf2 by curcumin: pharmacological implications","volume":"9","author":"Rahban","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.omto.2022.01.005_bib135","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3390\/cancers12071801","article-title":"Role of curcumin and (-)-epigallocatechin-3-O-gallate in bladder cancer treatment: a review","volume":"12","author":"Piwowarczyk","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omto.2022.01.005_bib136","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/aps.2010.122","article-title":"HPLC and LC-MS analysis of sinomenine and its application in pharmacokinetic studies in rats","volume":"31","author":"Long","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.omto.2022.01.005_bib137","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.3390\/molecules25204697","article-title":"Synthesis, molecular docking, and in\u00a0vitro boron neutron capture therapy assay of carboranyl sinomenine","volume":"25","author":"Cai","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.omto.2022.01.005_bib138","doi-asserted-by":"crossref","first-page":"9875","DOI":"10.1021\/ja0517116","article-title":"Substituted carborane-appended water-soluble single-wall carbon nanotubes: new approach to boron neutron capture therapy drug delivery","volume":"127","author":"Yinghuai","year":"2005","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.omto.2022.01.005_bib139","doi-asserted-by":"crossref","first-page":"103090","DOI":"10.1016\/j.bioorg.2019.103090","article-title":"Synthesis and in\u00a0vitro anti-tumor activity of carboranyl levodopa","volume":"90","author":"Zhu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib140","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.bmc.2018.10.041","article-title":"Design and synthesis of boron containing monosaccharides by the hydroboration of d-glucal for use in boron neutron capture therapy (BNCT)","volume":"26","author":"Itoh","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib141","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.3390\/molecules23102451","article-title":"Oligosaccharides derived from red seaweed: production, properties, and potential health and cosmetic applications","volume":"23","author":"Cheong","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.omto.2022.01.005_bib142","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1021\/acs.molpharmaceut.0c00630","article-title":"Addressing the biochemical foundations of a glucose-based \"Trojan horse\"-strategy to boron neutron capture therapy: from chemical synthesis to in\u00a0vitro assessment","volume":"17","author":"Matovi\u0107","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omto.2022.01.005_bib143","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1021\/acs.molpharmaceut.0c00917","article-title":"Exploring the biochemical foundations of a successful GLUT1-targeting strategy to BNCT: chemical synthesis and in\u00a0vitro evaluation of the entire positional isomer library of ortho-carboranylmethyl-bearing glucoconjugates","volume":"18","author":"Matovi\u0107","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omto.2022.01.005_bib144","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1021\/bc960050m","article-title":"Bispecific antibody mediated targeting of nido-carboranes to human colon carcinoma cells","volume":"7","author":"Primus","year":"1996","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib145","first-page":"2581","article-title":"Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors","volume":"16","author":"Liu","year":"1996","journal-title":"Anticancer Res."},{"key":"10.1016\/j.omto.2022.01.005_bib146","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41573-019-0028-1","article-title":"Bispecific antibodies: a mechanistic review of the pipeline","volume":"18","author":"Labrijn","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omto.2022.01.005_bib147","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/cancers13020287","article-title":"Overcoming challenges for CD3-bispecific antibody therapy in solid tumors","volume":"13","author":"Middelburg","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omto.2022.01.005_bib148","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrc1071","article-title":"Photodynamic therapy for cancer","volume":"3","author":"Dolmans","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omto.2022.01.005_bib149","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.bmcl.2014.01.054","article-title":"Synthesis and biological evaluation of new boron-containing chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer","volume":"24","author":"Asano","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.omto.2022.01.005_bib150","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/cancers12051334","article-title":"Boron neutron capture therapy and photodynamic therapy for high-grade meningiomas","volume":"12","author":"Nakahara","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omto.2022.01.005_bib151","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jphotobiol.2014.07.008","article-title":"Synthesis and biological evaluation of new BSH-conjugated chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer","volume":"140","author":"Asano","year":"2014","journal-title":"J.\u00a0Photochem. Photobiol. B"},{"key":"10.1016\/j.omto.2022.01.005_bib152","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1039\/D1BM00730K","article-title":"Ru(II) and Ir(III) phenanthroline-based photosensitisers bearing o-carborane: PDT agents with boron carriers for potential BNCT","volume":"9","author":"Conway-Kenny","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.omto.2022.01.005_bib153","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1021\/ol060946z","article-title":"Efficient microwave-assisted synthesis of amine-substituted tetrakis(pentafluorophenyl)porphyrin","volume":"8","author":"Samaroo","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.omto.2022.01.005_bib154","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1039\/b807836j","article-title":"Synthesis and biological investigations of tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC)","volume":"6","author":"Hao","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib155","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jorganchem.2008.11.037","article-title":"Cobaltacarborane-phthalocyanine conjugates: syntheses and photophysical properties","volume":"694","author":"Li","year":"2009","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib156","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pdpdt.2009.06.001","article-title":"Chlorin e6-based photosensitizers for photodynamic therapy and photodiagnosis","volume":"6","author":"Juzeniene","year":"2009","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.omto.2022.01.005_bib157","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1166\/jbn.2014.1738","article-title":"Cellular uptake and photosensitizing properties of quantum dot-chlorin e6 complex: in\u00a0vitro study","volume":"10","author":"Steponkiene","year":"2014","journal-title":"J.\u00a0Biomed. Nanotechnol."},{"key":"10.1016\/j.omto.2022.01.005_bib158","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.actbio.2015.08.027","article-title":"Photodynamic therapy of melanoma skin cancer using carbon dot-chlorin e6-hyaluronate conjugate","volume":"26","author":"Beack","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.omto.2022.01.005_bib159","doi-asserted-by":"crossref","first-page":"8176","DOI":"10.1021\/acsami.5b01027","article-title":"Chlorin e6 conjugated poly(dopamine) nanospheres as PDT\/PTT dual-modal therapeutic agents for enhanced cancer therapy","volume":"7","author":"Zhang","year":"2015","journal-title":"ACS Appl. Mater. Inter."},{"key":"10.1016\/j.omto.2022.01.005_bib160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/187152006776119135","article-title":"Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy","volume":"6","author":"Renner","year":"2006","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib161","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1039\/b715363e","article-title":"Cyclic oxonium derivatives of polyhedral boron hydrides and their synthetic applications","author":"Semioshkin","year":"2008","journal-title":"Dalton Trans."},{"key":"10.1016\/j.omto.2022.01.005_bib162","doi-asserted-by":"crossref","first-page":"17239","DOI":"10.1002\/chem.201803178","article-title":"Metallacarboranes on the road to anticancer therapies: cellular uptake, DNA interaction, and biological evaluation of cobaltabisdicarbollide [COSAN]","volume":"24","author":"Fuentes","year":"2018","journal-title":"Chemistry"},{"key":"10.1016\/j.omto.2022.01.005_bib163","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4155\/fmc-2020-0029","article-title":"Conjugate of chlorin \u0435(6) with iron bis(dicarbollide) nanocluster: synthesis and biological properties","volume":"12","author":"Ignatova","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib164","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/lsm.21026","article-title":"Application of a novel boronated porphyrin (H2OCP) as a dual sensitizer for both PDT and BNCT","volume":"43","author":"Hiramatsu","year":"2011","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.omto.2022.01.005_bib165","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/jcmm.14009","article-title":"Unveiling Ga(III) phthalocyanine\u2014a different photosensitizer in neuroblastoma cellular model","volume":"23","author":"Constantin","year":"2019","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.omto.2022.01.005_bib166","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cplu.201800560","article-title":"A phthalocyanine-ortho-carborane conjugate for boron neutron capture therapy: synthesis, physicochemical properties, and in\u00a0vitro tests","volume":"84","author":"Nar","year":"2019","journal-title":"Chempluschem."},{"key":"10.1016\/j.omto.2022.01.005_bib167","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/open.201800166","article-title":"Porphyrinic ionic liquid dyes: synthesis and characterization","volume":"7","author":"Li","year":"2018","journal-title":"ChemistryOpen"},{"key":"10.1016\/j.omto.2022.01.005_bib168","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cphc.201701318","article-title":"How does the encapsulation of porphyrinic photosensitizers into polymer matrices affect their self-association and dynamic properties?","volume":"19","author":"Gjuroski","year":"2018","journal-title":"Chemphyschem."},{"key":"10.1016\/j.omto.2022.01.005_bib169","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.3390\/molecules26071942","article-title":"Probing the interactions of porphyrins with macromolecules using NMR spectroscopy techniques","volume":"26","author":"Gjuroski","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.omto.2022.01.005_bib170","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/lsm.20361","article-title":"Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications","volume":"38","author":"Jori","year":"2006","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.omto.2022.01.005_bib171","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1016\/j.bmc.2006.05.026","article-title":"Synthesis and cellular studies of a carboranylchlorin for the PDT and BNCT of tumors","volume":"14","author":"Luguya","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib172","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1021\/jm061036q","article-title":"Structure-activity relationship among purpurinimides and bacteriopurpurinimides: trifluoromethyl substituent enhanced the photosensitizing efficacy","volume":"50","author":"Gryshuk","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib173","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/jps.24317","article-title":"Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy","volume":"104","author":"Hiramatsu","year":"2015","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.omto.2022.01.005_bib174","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1016\/j.bmc.2017.10.013","article-title":"Design and synthesis of p-carborane-containing sulfamates as multitarget anti-breast cancer agents","volume":"25","author":"Kaise","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib175","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/14756366.2020.1758692","article-title":"Recent progress in the development of steroid sulphatase inhibitors\u2014examples of the novel and most promising compounds from the last decade","volume":"35","author":"Da\u015bko","year":"2020","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib176","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jacc.2019.12.049","article-title":"Menopause-related estrogen decrease and the pathogenesis of HFpEF: JACC review topic of the week","volume":"75","author":"Sabbatini","year":"2020","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.omto.2022.01.005_bib177","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11357-020-00263-4","article-title":"Estrogen receptor involvement in vascular cognitive impairment and vascular dementia pathogenesis and treatment","volume":"43","author":"Nguyen","year":"2021","journal-title":"Geroscience"},{"key":"10.1016\/j.omto.2022.01.005_bib178","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/cancers12061647","article-title":"Estrogen signaling and its potential as a target for therapy in ovarian cancer","volume":"12","author":"Langdon","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omto.2022.01.005_bib179","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.tem.2020.06.001","article-title":"Estrogen-mediated gaseous signaling molecules in cardiovascular disease","volume":"31","author":"Teoh","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.omto.2022.01.005_bib180","doi-asserted-by":"crossref","first-page":"102468","DOI":"10.1016\/j.autrev.2020.102468","article-title":"Estrogen, estrogen-like molecules and autoimmune diseases","volume":"19","author":"Merrheim","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.omto.2022.01.005_bib181","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1021\/acs.jmedchem.1c00555","article-title":"Structure-activity relationship of para-carborane selective estrogen receptor \u03b2 agonists","volume":"64","author":"Sedl\u00e1k","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib182","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejmech.2016.06.029","article-title":"Design, synthesis, and anti-proliferative activity of 1-(4-methoxyphenyl)-12-hydroxymethyl-p-carborane derivatives","volume":"122","author":"Kaise","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib183","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1016\/j.bmc.2018.06.007","article-title":"Novel androgen receptor full antagonists: design, synthesis, and a docking study of glycerol and aminoglycerol derivatives that contain p-carborane cages","volume":"26","author":"Kaise","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib184","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1016\/j.bmc.2008.07.055","article-title":"Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring","volume":"16","author":"Ohta","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib185","doi-asserted-by":"crossref","first-page":"115554","DOI":"10.1016\/j.bmc.2020.115554","article-title":"A critical update on the strategies towards modulators targeting androgen receptors","volume":"28","author":"Luan","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib186","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41574-020-0336-x","article-title":"11-Oxygenated androgens in health and disease","volume":"16","author":"Turcu","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.omto.2022.01.005_bib187","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3389\/fimmu.2020.01356","article-title":"Impact of androgens on inflammation-related lipid mediator biosynthesis in innate immune cells","volume":"11","author":"Pace","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omto.2022.01.005_bib188","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41568-020-0267-9","article-title":"Prostate carcinogenesis: inflammatory storms","volume":"20","author":"de Bono","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omto.2022.01.005_bib189","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/17474124.2018.1406307","article-title":"New insights into the role of vitamin D in hepatocellular carcinoma","volume":"12","author":"Wu","year":"2018","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omto.2022.01.005_bib190","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.3390\/molecules25143219","article-title":"Vitamin D signaling in inflammation and cancer: molecular mechanisms and therapeutic implications","volume":"25","author":"El-Sharkawy","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.omto.2022.01.005_bib191","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41574-019-0312-5","article-title":"New aspects of vitamin D metabolism and action - addressing the skin as source and target","volume":"16","author":"Bikle","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.omto.2022.01.005_bib192","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3389\/fimmu.2020.00820","article-title":"Vitamin D and its potential interplay with pain signaling pathways","volume":"11","author":"Habib","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omto.2022.01.005_bib193","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1039\/C5SC03084F","article-title":"Carborane-based design of a potent vitamin D receptor agonist","volume":"7","author":"Otero","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.omto.2022.01.005_bib194","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11060-005-0603-7","article-title":"HER1\/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme","volume":"74","author":"Raizer","year":"2005","journal-title":"J.\u00a0Neurooncol."},{"key":"10.1016\/j.omto.2022.01.005_bib195","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1186\/s12885-021-08366-7","article-title":"Rac inhibition as a novel therapeutic strategy for EGFR\/HER2 targeted therapy resistant breast cancer","volume":"21","author":"Borrero-Garc\u00eda","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omto.2022.01.005_bib196","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.annonc.2019.10.007","article-title":"Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives","volume":"31","author":"Martinelli","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.omto.2022.01.005_bib197","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canlet.2019.10.030","article-title":"EGFR-mediated autophagy in tumourigenesis and therapeutic resistance","volume":"469","author":"Wu","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omto.2022.01.005_bib198","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10549-012-2289-9","article-title":"Role of epidermal growth factor receptor in breast cancer","volume":"136","author":"Masuda","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.omto.2022.01.005_bib199","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Normanno","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.omto.2022.01.005_bib200","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.canlet.2016.11.008","article-title":"EAI045: the fourth-generation EGFR inhibitor overcoming T790M and C797S resistance","volume":"385","author":"Wang","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omto.2022.01.005_bib201","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1002\/chem.201705181","article-title":"Discovery of potent EGFR inhibitors through the incorporation of a 3D-aromatic-boron-rich-cluster into the 4-anilinoquinazoline scaffold: potential drugs for glioma treatment","volume":"24","author":"Couto","year":"2018","journal-title":"Chemistry"},{"key":"10.1016\/j.omto.2022.01.005_bib202","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/j.bmc.2019.05.013","article-title":"Structure-based drug design of novel carborane-containing nicotinamide phosphoribosyltransferase inhibitors","volume":"27","author":"Asawa","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib203","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.3390\/molecules25163633","article-title":"Structural basis of beneficial design for effective nicotinamide phosphoribosyltransferase inhibitors","volume":"25","author":"Tanuma","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.omto.2022.01.005_bib204","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.semcdb.2019.05.001","article-title":"Targeting metabolic reprogramming in metastatic melanoma: the key role of nicotinamide phosphoribosyltransferase (NAMPT)","volume":"98","author":"Audrito","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.omto.2022.01.005_bib205","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.tibs.2020.05.010","article-title":"Location, location, location: compartmentalization of NAD(+) synthesis and functions in mammalian cells","volume":"45","author":"Cambronne","year":"2020","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.omto.2022.01.005_bib206","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/cplu.202000717","article-title":"Cobalt bis(dicarbollide) alkylsulfonamides: potent and highly selective inhibitors of tumor specific carbonic anhydrase IX","volume":"86","author":"Gr\u00fcner","year":"2021","journal-title":"Chempluschem."},{"key":"10.1016\/j.omto.2022.01.005_bib207","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/cbic.202100121","article-title":"Inhibitors of CA IX enzyme based on polyhedral boron compounds","volume":"22","author":"Kugler","year":"2021","journal-title":"Chembiochem."},{"key":"10.1016\/j.omto.2022.01.005_bib208","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00018-020-03697-3","article-title":"Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain","volume":"78","author":"Langella","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.omto.2022.01.005_bib209","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41416-019-0642-z","article-title":"Carbonic anhydrase IX and acid transport in cancer","volume":"122","author":"Becker","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omto.2022.01.005_bib210","doi-asserted-by":"crossref","first-page":"9560","DOI":"10.1021\/acs.jmedchem.9b00945","article-title":"Metallacarborane sulfamides: unconventional, specific, and highly selective inhibitors of carbonic anhydrase IX","volume":"62","author":"Gr\u00fcner","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib211","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3390\/v12111275","article-title":"Darunavir-resistant HIV-1 protease constructs uphold a conformational selection hypothesis for drug resistance","volume":"12","author":"Liu","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.omto.2022.01.005_bib212","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/17460441.2020.1773428","article-title":"The recent application of 3D-QSAR and docking studies to novel HIV-protease inhibitor drug discovery","volume":"15","author":"Olotu","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.omto.2022.01.005_bib213","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3390\/molecules25081800","article-title":"Natural bioactive compounds from fungi as potential candidates for protease inhibitors and immunomodulators to apply for coronaviruses","volume":"25","author":"Suwannarach","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.omto.2022.01.005_bib214","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1021\/acs.jmedchem.5b01697","article-title":"Recent progress in the development of HIV-1 protease inhibitors for the treatment of HIV\/AIDS","volume":"59","author":"Ghosh","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib215","doi-asserted-by":"crossref","first-page":"15137","DOI":"10.1074\/jbc.REV119.006901","article-title":"Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition","volume":"294","author":"Engelman","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib216","article-title":"Cabergoline: a review of its use in the inhibition of lactation for women living with HIV","volume":"22","author":"Tulloch","year":"2019","journal-title":"J.\u00a0Int. AIDS Soc."},{"key":"10.1016\/j.omto.2022.01.005_bib217","doi-asserted-by":"crossref","first-page":"15394","DOI":"10.1073\/pnas.0507577102","article-title":"From nonpeptide toward noncarbon protease inhibitors: metallacarboranes as specific and potent inhibitors of HIV protease","volume":"102","author":"C\u00edgler","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.omto.2022.01.005_bib218","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1021\/jm8002334","article-title":"Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance","volume":"51","author":"Koz\u00edsek","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib219","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1021\/jm9011388","article-title":"Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes","volume":"52","author":"Rez\u00e1cov\u00e1","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib220","doi-asserted-by":"crossref","first-page":"2749173","DOI":"10.1155\/2019\/2749173","article-title":"Emerging roles of 5-lipoxygenase phosphorylation in inflammation and cell death","volume":"2019","author":"Sun","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.omto.2022.01.005_bib221","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.bbi.2020.03.022","article-title":"5-Lipoxygenase pathway and its downstream cysteinyl leukotrienes as potential therapeutic targets for Alzheimer's disease","volume":"88","author":"Chen","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.omto.2022.01.005_bib222","doi-asserted-by":"crossref","first-page":"101359","DOI":"10.1016\/j.arr.2021.101359","article-title":"5-Lipoxygenase as an emerging target against age-related brain disorders","volume":"69","author":"Yan","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.omto.2022.01.005_bib223","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10555-018-9742-0","article-title":"Targeting the enzymes involved in arachidonic acid metabolism to improve radiotherapy","volume":"37","author":"Kim","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.omto.2022.01.005_bib224","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/cmdc.201700309","article-title":"CarbORev-5901: the first carborane-based inhibitor of the 5-lipoxygenase pathway","volume":"12","author":"Kuhnert","year":"2017","journal-title":"ChemMedChem."},{"key":"10.1016\/j.omto.2022.01.005_bib225","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/cmdc.201800651","article-title":"Carborane-based analogues of 5-lipoxygenase inhibitors Co-inhibit heat shock protein 90 in HCT116 cells","volume":"14","author":"Kuhnert","year":"2019","journal-title":"ChemMedChem."},{"key":"10.1016\/j.omto.2022.01.005_bib226","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1038\/s41598-020-59059-3","article-title":"Carboranyl derivatives of rofecoxib with cytostatic activity against human melanoma and colon cancer cells","volume":"10","author":"Buzharevski","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omto.2022.01.005_bib227","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41569-020-0366-z","article-title":"Cardiovascular effects and safety of (non-aspirin) NSAIDs","volume":"17","author":"Schjerning","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.omto.2022.01.005_bib228","doi-asserted-by":"crossref","first-page":"637504","DOI":"10.3389\/fonc.2021.637504","article-title":"Cyclooxygenase-2 inhibitor: a potential combination strategy with immunotherapy in cancer","volume":"11","author":"Pu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omto.2022.01.005_bib229","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.1007\/s12035-020-02087-x","article-title":"The role of brain cyclooxygenase-2 (Cox-2) beyond neuroinflammation: neuronal homeostasis in memory and anxiety","volume":"57","author":"L\u00f3pez","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.omto.2022.01.005_bib230","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bbamem.2018.12.009","article-title":"Carborane derivatives of 1,2,3-triazole depolarize mitochondria by transferring protons through the lipid part of membranes","volume":"1861","author":"Rokitskaya","year":"2019","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.omto.2022.01.005_bib231","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/jpm11060470","article-title":"Conjugation of natural triterpenic acids with delocalized lipophilic cations: selective targeting cancer cell mitochondria","volume":"11","author":"Spivak","year":"2021","journal-title":"J.\u00a0Pers Med."},{"key":"10.1016\/j.omto.2022.01.005_bib232","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1158\/1940-6207.CAPR-20-0425","article-title":"Mitochondria as a novel target for cancer chemoprevention: emergence of mitochondrial-targeting agents","volume":"14","author":"Huang","year":"2021","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.omto.2022.01.005_bib233","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s11095-016-1930-4","article-title":"Pharmacological development of target-specific delocalized lipophilic cation-functionalized carboranes for cancer therapy","volume":"33","author":"Tseligka","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.omto.2022.01.005_bib234","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/cncr.25565","article-title":"Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis","volume":"117","author":"Kramer","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.omto.2022.01.005_bib235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.semcancer.2019.07.007","article-title":"Revisiting the hallmarks of cancer: the role of hyaluronan","volume":"62","author":"Caon","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.omto.2022.01.005_bib236","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-020-00303-7","article-title":"Chitinase-3 like-protein-1 function and its role in diseases","volume":"5","author":"Zhao","year":"2020","journal-title":"Signal Transduct Target Ther."},{"key":"10.1016\/j.omto.2022.01.005_bib237","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/bm0607426","article-title":"Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy","volume":"8","author":"Meo","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.omto.2022.01.005_bib238","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/mabi.200700304","article-title":"Novel types of carborane-carrier hyaluronan derivatives via \"click chemistry\"","volume":"8","author":"Di Meo","year":"2008","journal-title":"Macromol Biosci."},{"key":"10.1016\/j.omto.2022.01.005_bib239","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1080\/10717544.2018.1450910","article-title":"Application of hyaluronic acid as carriers in drug delivery","volume":"25","author":"Huang","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.omto.2022.01.005_bib240","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2018.04.015","article-title":"Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system","volume":"278","author":"Huang","year":"2018","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omto.2022.01.005_bib241","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3390\/polym12081800","article-title":"Hyaluronic acid: the influence of molecular weight on structural, physical, physico-chemical, and degradable properties of biopolymer","volume":"12","author":"Snetkov","year":"2020","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.omto.2022.01.005_bib242","doi-asserted-by":"crossref","first-page":"111826","DOI":"10.1016\/j.colsurfb.2021.111826","article-title":"Hyaluronic acid-decorated carborane-TAT conjugation nanomicelles: a potential boron agent with enhanced selectivity of tumor cellular uptake","volume":"204","author":"Quan","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.omto.2022.01.005_bib243","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1002\/cbic.202000131","article-title":"Histone deacetylase 2 (HDAC2) inhibitors containing boron","volume":"21","author":"Kavianpour","year":"2020","journal-title":"Chembiochem."},{"key":"10.1016\/j.omto.2022.01.005_bib244","doi-asserted-by":"crossref","first-page":"113332","DOI":"10.1016\/j.ejmech.2021.113332","article-title":"Histone deacetylase 2: a potential therapeutic target for cancer and neurodegenerative disorders","volume":"216","author":"Gediya","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib245","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.drudis.2021.04.013","article-title":"Epigenetics and therapeutic targets in gastrointestinal malignancies","volume":"26","author":"Nagaraju","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.omto.2022.01.005_bib246","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1021\/acs.jmedchem.0c01676","article-title":"Dissecting histone deacetylase 3 in multiple disease conditions: selective inhibition as a promising therapeutic strategy","volume":"64","author":"Adhikari","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.omto.2022.01.005_bib247","first-page":"269","article-title":"Vorinostat in autophagic cell death: a critical insight into autophagy-mediated, -associated and -dependent cell death for cancer prevention","author":"Patra","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.omto.2022.01.005_bib248","doi-asserted-by":"crossref","first-page":"102089","DOI":"10.1016\/j.redox.2021.102089","article-title":"Role of acetylation in doxorubicin-induced cardiotoxicity","volume":"46","author":"Li","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.omto.2022.01.005_bib249","doi-asserted-by":"crossref","first-page":"11873","DOI":"10.1039\/D1SC02268G","article-title":"Borinostats: solid-phase synthesis of carborane-capped histone deacetylase inhibitors with a tailor-made selectivity profile","volume":"12","author":"Selg","year":"2021","journal-title":"Chem. Sci."}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770522000092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770522000092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:24:47Z","timestamp":1762496687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770522000092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":249,"alternative-id":["S2372770522000092"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2022.01.005","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carboranes as unique pharmacophores in antitumor medicinal chemistry","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2022.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}]}}